Author:
Brault L,Menter T,Obermann E C,Knapp S,Thommen S,Schwaller J,Tzankov A
Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. Adam M, Pogacic V, Bendit M, Chappuis R, Nawijn MC, Duyster J, Fox CJ, Thompson CB, Cools J, Schwaller J (2006) Targeting PIM kinases impairs survival of hematopoietic cells transformed by kinase inhibitor-sensitive and kinase inhibitor-resistant forms of Fms-like tyrosine kinase 3 and BCR/ABL. Cancer Res 66 (7): 3828–3835
2. Aho TL, Sandholm J, Peltola KJ, Mankonen HP, Lilly M, Koskinen PJ (2004) Pim-1 kinase promotes inactivation of the pro-apoptotic bad protein by phosphorylating it on the Ser112 gatekeeper site. FEBS Lett 571 (1–3): 43–49
3. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Levy R, Wilson W, Grever MR, Byrd JC, Botstein D, Brown PO, Staudt LM (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403 (6769): 503–511
4. Anizon F, Shtil AA, Danilenko VN, Moreau P (2010) Fighting tumor cell survival: advances in the design and evaluation of pim inhibitors. Curr Med Chem 17 (34): 4114–4133
5. Berns A, Mikkers H, Krimpenfort P, Allen J, Scheijen B, Jonkers J (1999) Identification and characterization of collaborating oncogenes in compound mutant mice. Cancer Res 59 (7 Suppl): 1773s–1777s
Cited by
57 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献